Talaromyces marneffei (Segretain et al.) Samson et al. (ATCC® 201706)

Strain Designations: NIHT 39-315-32 [IFM 47288]  /  Product Format: frozen

Permits and Restrictions

View Permits

Deposited As Penicillium marneffei Segretain et al.
Strain Designations NIHT 39-315-32 [IFM 47288]
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Type Strain no
Preceptrol® no
Medium ATCC® Medium 324: Malt extract agar
ATCC® Medium 336: Potato dextrose agar (PDA)
ATCC® Medium 2003: Czapek yeast extract agar
Growth Conditions
Temperature: 24°C to 26°C
Atmosphere: Typical aerobic
Name of Depositor Y Mikami
Special Collection NCRR Contract
Chain of Custody
ATCC <-- Y Mikami <-- N. Poonwan
Human blood of HIV+ male, Lam-Pang Hospital, Thailand 6/13/95

Y Mikami, personal communication

Uehara M, et al. Penicillium marneffei isolated from a Thai AIDS patient with fungemia. Nippon Ishinkin Gakkai Zasshi 49: 205-209, 2008.

Lasker BA. Nucleotide sequence-based analysis for determining the molecular epidemiology of Penicillium marneffei. J Clin Microbiol 44: 3145-3153, 2006. PubMed: 16954240

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation